Atai Life Sciences (NASDAQ: ATAI) and Beckley Psytech recently announced positive topline results from a phase 2b study of ...

This financing represents a major inflection point for Cybin and supports our position as a leader within our sector,” said Doug Drysdale, Chief Executive Officer of Cybin. "High Trail Capital is an ...